vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and GRAFTECH INTERNATIONAL LTD (EAF). Click either name above to swap in a different company.

GRAFTECH INTERNATIONAL LTD is the larger business by last-quarter revenue ($125.1M vs $121.8M, roughly 1.0× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -34.6%, a 38.8% gap on every dollar of revenue. On growth, GRAFTECH INTERNATIONAL LTD posted the faster year-over-year revenue change (11.9% vs -1.4%). Core Laboratories Inc. produced more free cash flow last quarter ($517.0K vs $-27.1M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -4.6%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

GrafTech International Ltd. is a manufacturer of graphite electrodes and petroleum coke, which are essential for the production of electric arc furnace steel and other metals. Headquartered in Brooklyn Heights, Ohio, it has manufacturing facilities in Calais, France;Pamplona, Spain; Monterrey, Mexico; and St. Marys, Pennsylvania.

CLB vs EAF — Head-to-Head

Bigger by revenue
EAF
EAF
1.0× larger
EAF
$125.1M
$121.8M
CLB
Growing faster (revenue YoY)
EAF
EAF
+13.3% gap
EAF
11.9%
-1.4%
CLB
Higher net margin
CLB
CLB
38.8% more per $
CLB
4.2%
-34.6%
EAF
More free cash flow
CLB
CLB
$27.6M more FCF
CLB
$517.0K
$-27.1M
EAF
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-4.6%
EAF

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
EAF
EAF
Revenue
$121.8M
$125.1M
Net Profit
$5.1M
$-43.3M
Gross Margin
-7.8%
Operating Margin
1.5%
Net Margin
4.2%
-34.6%
Revenue YoY
-1.4%
11.9%
Net Profit YoY
-10.0%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
EAF
EAF
Q1 26
$121.8M
$125.1M
Q4 25
$138.3M
$116.5M
Q3 25
$134.5M
$144.0M
Q2 25
$130.2M
$131.8M
Q1 25
$123.6M
$111.8M
Q4 24
$129.2M
$134.2M
Q3 24
$134.4M
$130.7M
Q2 24
$130.6M
$137.3M
Net Profit
CLB
CLB
EAF
EAF
Q1 26
$5.1M
$-43.3M
Q4 25
$4.9M
$-65.1M
Q3 25
$14.2M
$-28.5M
Q2 25
$10.6M
$-86.9M
Q1 25
$-154.0K
$-39.4M
Q4 24
$7.4M
$-49.5M
Q3 24
$11.7M
$-36.1M
Q2 24
$9.0M
$-14.8M
Gross Margin
CLB
CLB
EAF
EAF
Q1 26
-7.8%
Q4 25
20.8%
-20.9%
Q3 25
22.0%
7.2%
Q2 25
20.3%
0.0%
Q1 25
19.5%
-1.5%
Q4 24
17.8%
-7.8%
Q3 24
20.5%
-9.2%
Q2 24
21.2%
2.9%
Operating Margin
CLB
CLB
EAF
EAF
Q1 26
1.5%
Q4 25
11.5%
-33.6%
Q3 25
15.6%
-3.6%
Q2 25
11.7%
-11.0%
Q1 25
3.6%
-16.3%
Q4 24
11.0%
-18.6%
Q3 24
14.7%
-20.1%
Q2 24
12.3%
-2.0%
Net Margin
CLB
CLB
EAF
EAF
Q1 26
4.2%
-34.6%
Q4 25
3.6%
-55.9%
Q3 25
10.6%
-19.8%
Q2 25
8.2%
-65.9%
Q1 25
-0.1%
-35.2%
Q4 24
5.7%
-36.9%
Q3 24
8.7%
-27.6%
Q2 24
6.9%
-10.7%
EPS (diluted)
CLB
CLB
EAF
EAF
Q1 26
$0.11
Q4 25
$0.11
$-6.86
Q3 25
$0.30
$-1.10
Q2 25
$0.22
$-0.34
Q1 25
$0.00
$-0.15
Q4 24
$0.15
$-3.51
Q3 24
$0.25
$-1.40
Q2 24
$0.19
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
EAF
EAF
Cash + ST InvestmentsLiquidity on hand
$22.8M
$120.2M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$275.1M
Total Assets
$587.7M
$997.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
EAF
EAF
Q1 26
$22.8M
$120.2M
Q4 25
$22.7M
Q3 25
$25.6M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
$120.7M
Total Debt
CLB
CLB
EAF
EAF
Q1 26
$1.1B
Q4 25
$110.3M
$1.1B
Q3 25
$114.1M
$1.1B
Q2 25
$124.6M
$1.1B
Q1 25
$124.4M
$1.1B
Q4 24
$126.1M
$1.1B
Q3 24
$139.9M
$929.5M
Q2 24
$147.6M
$928.2M
Stockholders' Equity
CLB
CLB
EAF
EAF
Q1 26
$275.1M
Q4 25
$266.0M
$-259.6M
Q3 25
$271.3M
$-194.4M
Q2 25
$261.3M
$-168.4M
Q1 25
$253.4M
$-105.3M
Q4 24
$246.6M
$-78.9M
Q3 24
$250.7M
$-9.0M
Q2 24
$240.3M
$16.2M
Total Assets
CLB
CLB
EAF
EAF
Q1 26
$587.7M
$997.2M
Q4 25
$584.0M
$1.0B
Q3 25
$591.4M
$1.1B
Q2 25
$602.1M
$1.1B
Q1 25
$591.5M
$1.2B
Q4 24
$585.1M
$1.2B
Q3 24
$600.5M
$1.1B
Q2 24
$597.8M
$1.2B
Debt / Equity
CLB
CLB
EAF
EAF
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×
57.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
EAF
EAF
Operating Cash FlowLast quarter
$4.0M
$-14.9M
Free Cash FlowOCF − Capex
$517.0K
$-27.1M
FCF MarginFCF / Revenue
0.4%
-21.6%
Capex IntensityCapex / Revenue
9.7%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$-105.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
EAF
EAF
Q1 26
$4.0M
$-14.9M
Q4 25
$7.9M
$-20.9M
Q3 25
$8.5M
$24.7M
Q2 25
$13.9M
$-53.2M
Q1 25
$6.7M
$-32.2M
Q4 24
$20.6M
$-26.4M
Q3 24
$13.1M
$23.7M
Q2 24
$17.1M
$-36.9M
Free Cash Flow
CLB
CLB
EAF
EAF
Q1 26
$517.0K
$-27.1M
Q4 25
$5.0M
$-39.3M
Q3 25
$6.5M
$18.4M
Q2 25
$10.4M
$-57.1M
Q1 25
$3.9M
$-42.5M
Q4 24
$17.4M
$-39.2M
Q3 24
$10.4M
$19.7M
Q2 24
$14.3M
$-43.8M
FCF Margin
CLB
CLB
EAF
EAF
Q1 26
0.4%
-21.6%
Q4 25
3.6%
-33.7%
Q3 25
4.8%
12.8%
Q2 25
8.0%
-43.3%
Q1 25
3.1%
-38.0%
Q4 24
13.4%
-29.2%
Q3 24
7.7%
15.1%
Q2 24
10.9%
-31.9%
Capex Intensity
CLB
CLB
EAF
EAF
Q1 26
9.7%
Q4 25
2.1%
15.8%
Q3 25
1.5%
4.4%
Q2 25
2.7%
3.0%
Q1 25
2.3%
9.2%
Q4 24
2.5%
9.5%
Q3 24
2.0%
3.1%
Q2 24
2.2%
5.1%
Cash Conversion
CLB
CLB
EAF
EAF
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons